Trial Profile
Phase 2 study of ATRA and arsenic trioxide for acute promyelocytic leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2018
Price :
$35
*
At a glance
- Drugs Arsenic trioxide (Primary) ; Tretinoin (Primary)
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 18 Apr 2018 Status changed from not yet recruiting to completed.
- 13 Oct 2013 New trial record